INFUSION PUMPS MARKET ANALYSIS

Infusion Pump Market, By Product (Large Volume Infusion Pumps, Syringe Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, Elastomeric Pumps, and Implantable Pumps), By Technology (Traditional and Specialty), By Usage (Stationary and Ambulatory), By Application (Oncology, Diabetes, Gastroenterology, Pediatrics and Neonatology, Pain Management, and Others), End User (Hospitals, Home Healthcare Settings, Nursing Homes and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : May 2023
Code : CMI127
Pages :140
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Infusion Pump Market: Key Developments

In February 2023, Mindray announced the launch of BeneFusion i Series and u Series infusion systems featuring high precision, adaptive customization, and simplicity for guaranteed levels of medication safety in a variety of clinical settings.

In March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received the marketing approval from China’s National Medical Products Administration (NMPA) for its independently-developed new AutoEx Chemotherapy Infusion Pump (AutoEx).

In November 2020, Baxter received Health Canada marketing authorization for its new Novum IQ Infusion Platform. The marketing authorization in Canada includes Novum IQ large volume (LVP) and syringe infusion pumps, representing Baxter’s latest developments.

In June 2019, the U.S. Food and Drug Administration (FDA) issued 510(k) clearance for the Ivenix Infusion System, ushering in a new era of infusion systems designed to make infusions safer, while lowering the total cost of ownership. The Ivenix Infusion System meet the new FDA guidelines to address the recurring safety problems associated with infusion pumps.